| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From UMR 1054 Neuro-Gastroentérologie et Nutrition* and UMR 1089 Xénobiotiques, Institut National de la Recherche Agronomique, Toulouse, France; and the Unité d’Ecologie et Physiologie du Système Digestif, Institut National de la Recherche Agronomique, Jouy-en Josas, France
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Sprague-Dawley rats (200 to 250 g) and C3H/He mice were obtained from Janvier (Elevage Janvier, Le Genest St-Isle, France), kept at a constant temperature (23 ± 1°C) in a pathogen-free animal facility, and maintained on a 12-hour light/dark cycle. Food and water were available ad libitum. Germ-free C3H/He mice (25 to 30 g) were bred and maintained in isolators.
Measurement of Intestinal Permeability in Rats
Rats were placed in individual metabolic cages 24 hours before experiments. On the day of the experiment, rats were given ethanol, isocaloric amounts of dextrose by gavage, or water. Thirty minutes later, 0.7 µCi of 51Cr-ethylenediaminetetraacetic acid (EDTA) (Perkin Elmer Life Sciences, Courtaboeuf, France) in 0.5 ml of saline was orally administered. Urine was collected for 24 hours, then radioactivity was measured with a gamma counter. Intestinal permeability was expressed as the percentage of total radioactivity administered.
Measurement of Blood Endotoxins
Rats were anesthetized with pentobarbital 90 minutes after ethanol intake. A laparotomy was performed, and the portal vein was localized and punctured. Blood was centrifuged (10 minutes, 2500 rpm) and serum was recovered. The endotoxin level was measured using a limulus amoebocyte lysate-based kit (Cambrex, Verviers, Belgium). Samples were diluted 1:4 with sterile apyrogen water and heated 10 minutes at 70°C. Standards and samples were incubated 10 minutes at 37°C with limulus amoebocyte lysate and then 6 minutes with colorimetric substrate. The reaction was stopped with 25% acetic acid, and absorbance was read at 405 nm.
Blood Ethanol Assay
Two hours after ethanol administration by gavage, animals were anesthetized with ketamine (100 mg/kg) and acepromazine (0.5 mg/kg). After laparotomy, the abdominal aorta was isolated, and a blood puncture was performed using heparinized tubes. Blood samples were centrifuged at 1200 x g for 10 minutes, plasma was recovered and immediately analyzed. Ethanol was assayed by an enzymatic in vitro test (Roche Diagnostics, Meylan, France).
Colonic Acetaldehyde Determination by GC-MS
After sacrifice, samples of luminal content from the cecum and proximal colon were harvested, and acetaldehyde was assayed as described by Gukovskaya and colleagues.15 Homogenate (300 µl) was mixed with an equal volume of 6 mol/L HCl, containing 500 µmol/L of butyraldehyde as internal standard and 4 mg/ml of 2,4-dinitrophenylhydrazine (DNPH) to form a Schiff base. Samples were then incubated at 40°C for 1 hour, extracted with 3 ml of n-heptane, and vacuum-dried.
The residue was dissolved in 1 ml of n-hexane, and a 20 µl aliquot was diluted in 1 ml of n-hexane. One µl of the resulting solution was injected in the splitless mode into a Finnigan Polaris Q gas chromatograph-ion trap mass spectrometer fitted with an AS2000 autoinjector (Thermo Electron, Les Ulis, France). The chromatographic separation was achieved on a BPX5 capillary column (25 m x 0.22 mm ID, 0.25-µm film thickness) from SGE (Courtaboeuf, France). Helium was used as the carrier gas at a flow rate of 1 ml/minute. The oven temperature was programmed as follows: 100°C for 1 minute, then 100°C to 200°C at 20°C/minute, hold time of 5 minutes at 200°C, 200°C to 220°C at 5°C/minute and 220°C to 280°C at 30°C/minute with a final hold time of 4 minutes at 280°C. The injector and GC-MS interface temperatures were set at 250°C. EI mass spectra were generated at 70 eV at a source temperature of 220°C. Spectra were acquired from m/z 60 to m/z 350. Due to the formation of syn/anti-isomers during derivatization, DNPH-acetaldehyde was eluted in two peaks at 13.6 and 14.2 minutes, whereas DNPH-butyraldehyde gave two peaks at 16.3 and 16.7 minutes. Ion currents at m/z 224 and 252 were extracted for integration of the peaks corresponding to DNPH-acetaldehyde and DNPH-butyraldehyde, respectively. Acetaldehyde determinations were performed by internal standard calibration. The calibration curve was linear from 4 to 200 pg of acetaldehyde, and the limit of detection was estimated at 600 fg of acetaldehyde.
Ussing Chamber Experiments
Immediately after sacrifice, portions of proximal colon (exposed area, 0.5 cm2) were mounted into Ussing chamber (Physiological Instruments, San Diego, CA), each side containing 5 ml of Krebs buffer (NaCl, 118 mmol/L; KCl, 4.7; KH2PO4, 1.2; MgSO4, 1.2; NaHCO3, 25; glucose, 8.3; CaCl2, 2.5), continuously gassed with 95% O2/5% CO2. TER was monitored throughout the experiment to assess the viability of the tissue. After 20 minutes, fluorescein isothiocyanate-labeled 4-kd dextran was added at the mucosal side (2.2 mg/ml as final concentration). At the same time, ethanol (17 mmol/L), acetaldehyde (from 40 to 160 µmol/L), or buffer were added either in the serosal compartment (ethanol) or in the mucosal compartment (acetaldehyde). Fluorescence was measured at the serosal side after 60 minutes. Results were expressed as the flux of dextran crossing the epithelial barrier (nmol/hour/cm2).
Experimental Design
To determine the effects of ethanol on intestinal permeability, three groups of eight rats were given 1.5, 3.0, or 4.5 g/kg ethanol, three other groups received isocaloric amounts of dextrose. The role of the microflora was investigated on two groups of eight rats receiving antibiotics (1.0 g/L ampicillin and 0.5 g/L neomycin in drinking water) for 12 days. Ampicillin and neomycin are two broad-spectrum antibiotics that are not (neomycin) or weakly absorbed and, thus, are able target the commensal microbes. On the 12th day, one group was given 3.0 g/kg ethanol, the other was given dextrose, and the permeability to 51Cr-EDTA was assessed.
The involvement of mast cells was demonstrated on two groups of 16 rats, injected with either a mast cell membrane stabilizer (doxantrazole, 20 mg/kg i.p.) or its vehicle (NaHCO3, 5% w/v) 30 minutes before ethanol intake. In each group, eight animals received oral administration of 3.0 g/kg ethanol, eight other animals received dextrose. Ethanol blood levels were determined in two groups of conventional rats 2 hours after a 3.0 g/kg ethanol intake, one group being pretreated with antibiotics. Similar experiments were conducted in one group of germ-free C3H/He mice and one group of conventional C3H/He receiving 3.0 g/kg ethanol. Endotoxin blood levels were measured in three groups of rats. One group served as control, two groups were submitted to a 3.0 g/kg ethanol intake, one being pretreated with antibiotics. Colonic acetaldehyde content was determined on four groups of 10 rats. Two groups received 3.0 g/kg ethanol with or without pretreatment with antibiotics. Two other groups received dextrose, with or without pretreatment with antibiotics. Ussing chamber experiments were conducted on rats (n = 5 to 8 per group) treated with doxantrazole (20 mg/kg i.p.) or its vehicle (NaHCO3, 5% w/v) 30 minutes before sacrifice.
Chemicals
Chemicals were obtained from Sigma (Saint Quentin Fallavier, France). Doxantrazole [3-(1H-tetrazol-5-yl)-9H-thioxanten-9-one 10,10-dioxide monohydrate] was a gift from the Wellcome Trust (London, UK).
Statistics
Data were analyzed by one-way analysis of variance, followed by posthoc Dunnet’s multiple comparison test or Student’s t-test where appropriate. Differences were considered significant at P < 0.05.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Basal intestinal paracellular permeability to 51Cr-EDTA in rats was 2.3 ± 0.3%. Oral administration of dextrose at concentrations that mimic the caloric intake of ethanol (10.5, 21.0, and 31.5 kcal/kg) was devoid of effect (Figure 1)
. The lowest dose of ethanol (1.5 g/kg) did not induce any significant change in paracellular permeability (2.3 ± 0.1% versus 2.4 ± 0.2% in controls, P > 0.05). Higher ethanol intake at doses of 3.0 and 4.5 g/kg increased intestinal permeability by 45% (3.2 ± 0.2% versus 2.2 ± 0.2%, P < 0.05) and 59% (3.5 ± 0.4% versus 2.2 ± 0.1%, P < 0.05), respectively (Figure 1)
. Because a significant permeability increase was observed with 3.0 g/kg ethanol, this concentration was used thereafter.
|
A treatment with antibiotics significantly diminished basal intestinal permeability to 51Cr-EDTA (1.8 ± 0.1% versus 2.2 ± 0.1%, P < 0.01). Similarly, the ethanol-induced increase of intestinal permeability was abolished by antibiotic treatment (1.9 ± 0.1% versus 2.8 ± 0.2%, P < 0.01; Figure 2
). Ethanol blood concentration reached 75.7 ± 7.6 mg/dl 2 hours after a 3.0 g/kg oral ethanol intake. With antibiotic treatment, ethanolemia was nearly twofold for the same intake (155.8 ± 9.3 mg/dl, P < 0.001; Figure 3
). Similarly, for a 3.0 g/kg ethanol intake, plasma concentrations of ethanol were significantly increased in C3H/He germ-free mice (212.2 ± 17.7 mg/dl), compared with conventional mice (93.4 ± 6.5 mg/dl, P < 0.001; Figure 3
).
|
|
Ethanol 3.0 g/kg induced a significant increase of endotoxin levels in the portal blood (789.3 ± 73.7 UI/L versus 382.2 ± 34.2 UI/L for controls, P < 0.01; Figure 4
). A treatment with antibiotics inhibited the effects of ethanol, the endotoxin concentrations returning to basal values (433.8 ± 42.5 UI/L, P < 0.01 versus ethanol; Figure 4
).
|
Two hours after oral administration of dextrose (21.0 kcal/kg), the concentration of acetaldehyde in luminal content was 20.8 ± 1.4 µmol/L. Two hours after 3.0 g/kg ethanol intake, colonic concentration of acetaldehyde reached 132.6 ± 31.6 µmol/L (P < 0.05). However, the amount of acetaldehyde produced in situ strongly varied from one animal to another (Figure 5)
. Antibiotics partially inhibited the production of acetaldehyde (86.2 ± 10.9 µmol/L), and strongly reduced distribution data scattering.
|
The mast cell stabilizer doxantrazole (20 mg/kg i.p.) reduced the effect of a single 3.0 g/kg ethanol intake on intestinal permeability (2.5 ± 0.1% versus 3.0 ± 0.1%, P < 0.05; Figure 6
). This inhibition was partial because intestinal permeability after doxantrazole treatment remained higher than in dextrose-receiving animals (2.2 ± 0.1%, P < 0.05). Doxantrazole itself did not affect significantly basal permeability (P = 0.15).
|
A concentration of 17 mmol/L ethanol, mimicking the ethanol blood level 2 hours after a single 3.0 g/kg intake, added on the serosal side of rat colonic samples mounted in Ussing chambers had no effect on dextran flux across the tissue (Table 1)
. Conversely, 133 µmol/L acetaldehyde, a concentration similar to the one observed in the colonic lumen after ethanol ingestion, increased the dextran flux by 54% compared with control tissues (P < 0.05, Table 1
). Acetaldehyde also markedly induced a dose-dependent increase of the dextran flux across the epithelium, reaching significance at 120 µmol/L (Figure 7)
. In samples harvested from rats treated with doxantrazole, basal permeability to dextran was significantly reduced when compared with controls (P < 0.05). Acetaldehyde addition on colonic samples from doxantrazole-treated rats had no effect (Table 1)
.
|
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Alterations of the intestinal barrier in patients suffering alcoholic liver disease (ALD) are clearly established.4 An intact epithelium is necessary to prevent bacteria and endotoxin translocation into the internal milieu. Here, we show that a single alcoholization is sufficient to produce a significant increase in intestinal paracellular permeability to 51Cr-EDTA in rats. Although similar observations have been reported in humans,6 the leaky gut of alcoholics was first considered as a consequence of the liver disease. The hypothesis was that portal hypertension associated with ALD would be responsible for an acute venous congestion, edema, and ischemia, leading to mucosal damage.16 Our results are in agreement with a new concept proposing that mucosal damage is a prerequisite to develop ALD.4
Several underlying mechanisms through which ethanol may impair the mucosal barrier can be hypothesized. First, ethanol could act directly on epithelial cells. In 1982, Levitt and colleagues9 showed that ethanol concentrations after acute ingestion were identical in blood and intestinal lumen. This diffusion allows a direct contact between ethanol and enterocytes. Some studies have focused on this hypothesis using cell culture experiments by measuring TER and permeability to markers of cell monolayers. These studies revealed that ethanol concentrations of 5 to 10% must be reached to decrease TER and to increase permeability.8,17 Such concentrations might be present in the stomach and proximal duodenum, immediately after ethanol consumption, but could not be reached in the colonic lumen from diffusion from blood. In our model of explanted colonic tissue mounted in Ussing chamber, we did not observe any modification of permeability after ethanol addition, at a concentration mimicking the ethanol blood levels 2 hours after intake.
Second, the effect of ethanol could be related to acetaldehyde, which is produced by ethanol oxidation. In the colon, acetaldehyde can be generated either through cytochrome P450 2E1,18 or by indigenous bacterial species that are able to oxidize ethanol through an alcohol dehydrogenase activity.19 Moreover, some antibiotics have been found to decrease significantly the whole body ethanol metabolism.20 Our present data support these observations because a twofold increase of ethanol blood concentration was observed after antibiotic treatment in rats or in germ-free mice, in comparison with conventional animals. These results highlight a significant role for the gut microflora in ethanol metabolism, which may be responsible for half of the whole ethanol metabolic activity. Antibiotic treatment also blocks the effects of ethanol on gut permeability despite high ethanol blood concentration. In addition, the increase of portal blood endotoxins observed 90 minutes after alcohol intake is absent in antibiotic-treated animals. These results reinforce the hypothesis of an indirect effect of ethanol. Moreover, we have shown that significant acetaldehyde concentrations are present in the colonic content after ethanol intake. However, as observed by others,21 there were great interindividual variations in colonic acetaldehyde concentration. Although not significant, antibiotic treatment tends to reduce intracolonic concentration of acetaldehyde, and strongly diminishes the data scattering. Acetaldehyde is known to disrupt epithelial tight junctions of cell monolayers, through a mechanism involving a loss of phosphatase activity and an increased tyrosine kinase activity,11 resulting in an inhibition of the regulation of the phosphorylation-dephosphorylation balance of tight junction proteins. Interestingly, acetaldehyde may act on the epithelial barrier at concentration levels similar to those observed after ethanol intake. Visapaa and colleagues21 observed that colonic acetaldehyde may reach concentrations as high as 3 mmol/L, whereas in vitro studies have shown that 0.1 mmol/L acetaldehyde was able to impair the epithelial barrier.11 Our results show that 120 µmol/L acetaldehyde, ie, slightly lower that the mean luminal concentration after ethanol intake, increased the permeability to dextran of colonic samples mounted in Ussing chambers.
One study indicates that acetaldehyde at low concentration is a potent mast cell degranulator in vitro.14 Mast cells are immunocytes in close relationship with epithelia and receive signals from their host tissue, other immunocytes, and nerves. Their activation lead to degranulation and release of several mediators such as histamine, eicosanoids, cytokines, and chemokines.22 Several studies have shown that mast cells play a key role in the regulation of the epithelial physiology, especially regarding intestinal permeability.12,13,23 This is corroborated by our present observation, showing that in rats treated with the mast cell stabilizer doxantrazole, the in vitro basal permeability to dextran was significantly lower than for control animals. Doxantrazole is able to stabilize the mast cell membrane, thus inhibiting its degranulation, through still poorly understood mechanisms, despite its discovery in 1975.24 One study by Sadeghi-Hashjin and colleagues25 showed in isolated alveolar macrophages that doxantrazole was also a scavenger of free radicals. In our present study, such a mechanism appears unlikely because acetaldehyde has never been found associated with macrophage activation within the gut. Doxantrazole was also found to reduce slightly but not significantly basal permeability to 51Cr-EDTA in vivo. We demonstrated herein that the effects of ethanol intake on the increase of intestinal permeability to 51Cr-EDTA are blocked by a mast cell stabilizer in vivo. In addition, we also found that in doxantrazole-treated rats, acetaldehyde did not increase permeability to dextran in colonic samples mounted in Ussing chambers. It is noteworthy that a direct effect of acetaldehyde on tight junctions may occur independently of mast cells. Atkinson and Rao11 have indeed observed an increased phosphorylation of ZO-1, E-cadherin, and ß-catenin after 5 hours of contact between acetaldehyde and epithelial cell line monolayers.
In summary, our data suggest an original mechanism of action for alcohol-induced impairment of the gut mucosal barrier function. The deleterious effects of ethanol require the presence of the resident microflora, which is able to oxidize ethanol into acetaldehyde in situ. Acetaldehyde will thereafter stimulate mast cells, resulting in an alteration of the mucosal barrier function, which in turn may lead to a crossing of bacteria or other lumenal antigens as endotoxins toward the internal milieu.
|
Footnotes |
|---|
Supported by the Institut National de la Recherche Agronomique and the Institut de Recherche Scientifique sur les Boissons.
Accepted for publication December 29, 2005.
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  P. D. Cani, R. Bibiloni, C. Knauf, A. Waget, A. M. Neyrinck, N. M. Delzenne, and R. Burcelin Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice Diabetes, June 1, 2008; 57(6): 1470 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ferrier Significance of increased human colonic permeability in response to corticotrophin-releasing hormone (CRH) Gut, January 1, 2008; 57(1): 7 - 9. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
